Skip to main content
. 2021 Nov 21;27(43):7446–7461. doi: 10.3748/wjg.v27.i43.7446

Table 2.

Microbial changes as a result of several treatments in viral B and C hepatitis

Drug
Type of study
Changes in gut microbiota
Ref.
Entecavir Experimental (mice) Lachnospiraceae, Akkermansia, Alistipes, Escherichia, Shigella, Oscillibacter, Bilophila Li et al[127]
Clinical Clostridium sensu stricto 1, Erysipelotrichaceae UCG-007, Intestinibacter; ↓ Streptococcus, Atopobium, and Murdochiella Lu et al[128]
Direct antiviral agents in patients with HCV infection Clinical Phylum Firmicutes, genera Lachnospira Pérez-Matute et al[129]
Direct antiviral agents in patients with HCV-related liver cirrhosis Clinical Enterobacteriaceae, Staphylococcus and Veillonellaceae Ponziani et al[130]

HCV: Hepatitis C virus.